z-logo
open-access-imgOpen Access
Aktuelles rund um Imatinib
Author(s) -
J.E.A. Wolff,
Jonathan L. Finlay,
Kadri Altundağ,
Alexander Schmittel,
K. Schulze,
Gero Hütter,
Peter Krebs,
E. Thiel,
U. Keilholz,
Serdar Yalçın,
Özay Özkaya,
Nilüfer Güler,
A.S. Lübbe,
Wolfgang Grisold,
Martin J. van den Bent,
Roger Stupp,
A.A. Brandes,
Didier Lacombe,
D. Reinhardt,
S. Diekamp,
G. Fleischhack,
C. Corbacioglu,
H. Jürgens,
Michael Dworzak,
Gertjan J.L. Kaspers,
Ursula Creutzig,
C. Michel Zwaan,
Juri Ruf,
Holger Amthauer,
H. Oettle,
T. Steinmüller,
Michael A. Plotkin,
U. Pelzer,
H.-J. Scholman,
R. Felix,
P. Wust,
J. Sturm,
Michael Keese,
W. Golder,
R. Dollner,
C. Granzow,
Jochen A. Werner,
Allan B. Dietz,
Wolfgang Wick,
Wilhelm Küker,
Andrea Křivanová,
Roman Hájek,
M. Krejčí,
V. Ščudla,
Karel Indrák,
J. Bačovský,
Tomáš Büchler,
Adam Svobodník,
Zdeněk Adam,
Jens Mayer,
J. Vorlíček,
R. Voltz,
Francesc Graus
Publication year - 2004
Publication title -
oncology research and treatment
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000079461
Subject(s) - imatinib , medicine , myeloid leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom